OLB-AC: toward optimizing ligand bioactivities through deep graph learning and activity cliffs
Open Access
- 3 June 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 40 (6)
Abstract
Deep graph learning (DGL) has been widely employed in the realm of ligand-based virtual screening. Within this field, a key hurdle is the existence of activity cliffs (ACs), where minor chemical alterations can lead to significant changes in bioactivity. In response, several DGL models have been developed to enhance ligand bioactivity prediction in the presence of ACs. Yet, there remains a largely unexplored opportunity within ACs for optimizing ligand bioactivity, making it an area ripe for further investigation. We present a novel approach to simultaneously predict and optimize ligand bioactivities through DGL and ACs (OLB-AC). OLB-AC possesses the capability to optimize ligand molecules located near ACs, providing a direct reference for optimizing ligand bioactivities with the matching of original ligands. To accomplish this, a novel attentive graph reconstruction neural network and ligand optimization scheme are proposed. Attentive graph reconstruction neural network reconstructs original ligands and optimizes them through adversarial representations derived from their bioactivity prediction process. Experimental results on nine drug targets reveal that out of the 667 molecules generated through OLB-AC optimization on datasets comprising 974 low-activity, noninhibitor, or highly toxic ligands, 49 are recognized as known highly active, inhibitor, or nontoxic ligands beyond the datasets’ scope. The 27 out of 49 matched molecular pairs generated by OLB-AC reveal novel transformations not present in their training sets. The adversarial representations employed for ligand optimization originate from the gradients of bioactivity predictions. Therefore, we also assess OLB-AC’s prediction accuracy across 33 different bioactivity datasets. Results show that OLB-AC achieves the best Pearson correlation coefficient (r2) on 27/33 datasets, with an average improvement of 7.2%–22.9% against the state-of-the-art bioactivity prediction methods. The code and dataset developed in this work are available at github.com/Yueming-Yin/OLB-AC.Keywords
Funding Information
- National Natural Science Foundation of China (62371245)
This publication has 37 references indexed in Scilit:
- Representation and identification of activity cliffsExpert Opinion on Drug Discovery, 2017
- Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypesBiochimica et Biophysica Acta (BBA) - General Subjects, 2017
- Molecular graph convolutions: moving beyond fingerprintsJournal of Computer-Aided Molecular Design, 2016
- Advances in Activity Cliff ResearchMolecular Informatics, 2016
- GLASS: a comprehensive database for experimentally validated GPCR-ligand associationsBioinformatics, 2015
- Activity cliffs in drug discovery: Dr Jekyll or Mr Hyde?Drug Discovery Today, 2014
- Impact of distance-based metric learning on classification and visualization model performance and structure–activity landscapesJournal of Computer-Aided Molecular Design, 2014
- Recent Progress in Understanding Activity Cliffs and Their Utility in Medicinal ChemistryJournal of Medicinal Chemistry, 2013
- Compound Pathway Model To Capture SAR Progression: Comparison of Activity Cliff-Dependent and -Independent PathwaysJournal of Chemical Information and Modeling, 2013
- Online chemical modeling environment (OCHEM): web platform for data storage, model development and publishing of chemical informationJournal of Computer-Aided Molecular Design, 2011